ResearcherSecond Affiliated Hospital of Guangzhou Medical UniversityNo recent work listed

Xiaodong Song

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2543-1790; OpenAlex author ID A5101989645. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: none · 2022: 1 paper

Papers 2

Outcomes of using INTRABEAM mobile intraoperative radiotherapy system to treat locally advanced pancreatic cancer: case series and literature review Co-author DOI 10.21203/rs.3.rs-1969267/v1 ↗
Using the new INTRABEAM mobile intraoperative radiotherapy system during surgery for pancreatic cancer: a case report. Co-author DOI 10.1186/s13256-018-1906-6 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Huihong Liang · 2 shared papers, 2019–2022 · strength 0.31
- Paper Using the new INTRABEAM mobile intraoperative radiotherapy system during surgery for pancreatic cancer: a case report. DOI 10.1186/s13256-018-1906-6 ↗
- Paper Outcomes of using INTRABEAM mobile intraoperative radiotherapy system to treat locally advanced pancreatic cancer: case… DOI 10.21203/rs.3.rs-1969267/v1 ↗
Bingqing Du · 1 shared paper, 2022 · strength 0.15
- Paper Outcomes of using INTRABEAM mobile intraoperative radiotherapy system to treat locally advanced pancreatic cancer: case… DOI 10.21203/rs.3.rs-1969267/v1 ↗
Xiaofeng Jiang · 1 shared paper, 2022 · strength 0.15
- Paper Outcomes of using INTRABEAM mobile intraoperative radiotherapy system to treat locally advanced pancreatic cancer: case… DOI 10.21203/rs.3.rs-1969267/v1 ↗
Xuewei Yang · 1 shared paper, 2022 · strength 0.15
- Paper Outcomes of using INTRABEAM mobile intraoperative radiotherapy system to treat locally advanced pancreatic cancer: case… DOI 10.21203/rs.3.rs-1969267/v1 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.